These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 24649958

  • 1. Early repositioning through compound set enrichment analysis: a knowledge-recycling strategy.
    Temesi G, Bolgár B, Arany A, Szalai C, Antal P, Mátyus P.
    Future Med Chem; 2014 Apr; 6(5):563-75. PubMed ID: 24649958
    [Abstract] [Full Text] [Related]

  • 2. Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.
    Tan F, Yang R, Xu X, Chen X, Wang Y, Ma H, Liu X, Wu X, Chen Y, Liu L, Jia X.
    Mol Biosyst; 2014 May; 10(5):1126-38. PubMed ID: 24603772
    [Abstract] [Full Text] [Related]

  • 3. Biodiversity of small molecules--a new perspective in screening set selection.
    Petrone PM, Wassermann AM, Lounkine E, Kutchukian P, Simms B, Jenkins J, Selzer P, Glick M.
    Drug Discov Today; 2013 Jul; 18(13-14):674-80. PubMed ID: 23454345
    [Abstract] [Full Text] [Related]

  • 4. In silico drug repositioning: from large-scale transcriptome data to therapeutics.
    Kwon OS, Kim W, Cha HJ, Lee H.
    Arch Pharm Res; 2019 Oct; 42(10):879-889. PubMed ID: 31482491
    [Abstract] [Full Text] [Related]

  • 5. Integrating LINCS Data to Evaluate Cancer Transcriptome Modifying Potential of Small-molecule Compounds for Drug Repositioning.
    Zhao Y, Liu Y, Bai H.
    Comb Chem High Throughput Screen; 2021 Oct; 24(9):1340-1350. PubMed ID: 33109034
    [Abstract] [Full Text] [Related]

  • 6. A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network.
    Jadamba E, Shin M.
    Biomed Res Int; 2016 Oct; 2016():7147039. PubMed ID: 28127549
    [Abstract] [Full Text] [Related]

  • 7. PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures.
    Emon MA, Domingo-Fernández D, Hoyt CT, Hofmann-Apitius M.
    BMC Bioinformatics; 2020 Jun 05; 21(1):231. PubMed ID: 32503412
    [Abstract] [Full Text] [Related]

  • 8. Systematic drug repositioning for a wide range of diseases with integrative analyses of phenotypic and molecular data.
    Iwata H, Sawada R, Mizutani S, Yamanishi Y.
    J Chem Inf Model; 2015 Feb 23; 55(2):446-59. PubMed ID: 25602292
    [Abstract] [Full Text] [Related]

  • 9. Connections in pharmacology: innovation serving translational medicine.
    Montero-Melendez T, Perretti M.
    Drug Discov Today; 2014 Jul 23; 19(7):820-3. PubMed ID: 24316023
    [Abstract] [Full Text] [Related]

  • 10. In silico drug repositioning: what we need to know.
    Liu Z, Fang H, Reagan K, Xu X, Mendrick DL, Slikker W, Tong W.
    Drug Discov Today; 2013 Feb 23; 18(3-4):110-5. PubMed ID: 22935104
    [Abstract] [Full Text] [Related]

  • 11. Efficient hit and lead compound evaluation strategy based on off-rate screening by surface plasmon resonance.
    Liu L.
    J Med Chem; 2014 Apr 10; 57(7):2843-4. PubMed ID: 24654838
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In silico repositioning of approved drugs for rare and neglected diseases.
    Ekins S, Williams AJ, Krasowski MD, Freundlich JS.
    Drug Discov Today; 2011 Apr 10; 16(7-8):298-310. PubMed ID: 21376136
    [Abstract] [Full Text] [Related]

  • 16. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB, DeCaprio D.
    Curr Opin Chem Biol; 2010 Jun 10; 14(3):325-30. PubMed ID: 20457001
    [Abstract] [Full Text] [Related]

  • 17. Finding Hsp90 inhibitors by drug repurposing: the power of chemical genetics.
    Xiong M, Zhang HY.
    Drug Discov Today; 2012 Jun 10; 17(11-12):531-3. PubMed ID: 22469949
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mining small-molecule screens to repurpose drugs.
    Swamidass SJ.
    Brief Bioinform; 2011 Jul 10; 12(4):327-35. PubMed ID: 21715466
    [Abstract] [Full Text] [Related]

  • 20. Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling.
    Meslamani J, Li J, Sutter J, Stevens A, Bertrand HO, Rognan D.
    J Chem Inf Model; 2012 Apr 23; 52(4):943-55. PubMed ID: 22480372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.